Hypertension is one of the most prevalent chronic diseases in China. As of 2021, there are over 270 million people suffering from hypertension in our country, which is the most significant risk factor for the death of urban and rural residents due to cardiovascular and cerebrovascular diseases. China has now entered the stage of comprehensively building a Healthy China, and exploring the construction of a chronic disease management path with the integration of healthcare and prevention as the core has become an important trend. This specification is based on the existing content and process of hypertension integration of healthcare and prevention services, and formulates standardized service diagnostic and treatment norms for the integration of hypertension healthcare and prevention. The content of the specification mainly includes basic requirements for service provision, service content, service process, etc., aiming to optimize the primary diagnosis and treatment and health management process of hypertension, control the incidence and mortality of hypertension, and reduce and delay the occurrence of complications, thereby effectively building a primary prevention and treatment line for chronic diseases.